A. Corey

Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-1

Anthony W. Tolcher, Monica Mita, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 311 citations · Full text

Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

Ruth Plummer, Gerhardt Attard, Simon Pacey et al. · Clinical Cancer Research · 2007 · 243 citations · Full text

A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies

Sébastien J. Hotte, Hal W. Hirte, Eric X. Chen et al. · Clinical Cancer Research · 2008 · 189 citations

HGS-ETR1, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: Results of a phase 1 and PK study

Laura Q.M. Chow, S. Gail Eckhardt, Daniel L. Gustafson et al. · Journal of Clinical Oncology · 2006 · 34 citations

Immunology, Pathology, Cell Death +20

Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits

A. Corey, Thi‐Sau Migone, Sally D. Bolmer et al. · Toxins · 2013 · 32 citations · Full text

Toxinology, Microbial Pathogens, Antimicrobial Chemotherapy +17